September 8, 2016Categories News & AnalysisDanaher Strengthens Molecular Diagnostics Portfolio with $4B Acquisition of CepheidDanaher has announced the acquisition of medical diagnostics company Cepheid, bolstering their presence in the Molecular Diagnostics market. Danaher Corporation will pay $53 per share in […]